Aranesp is an anti-anemia medication used to fight the devastating effects of chemotherapy that gained FDA approval on September 17th of 2001. Chemotherapy is a way to battle cancerous cells that regrettably can cause anemia in patients because it inhibits the body's natural mechanism for producing red blood cells. The body needs these red blood cells in order to transport oxygen throughout the body and a lack of these cells can cause severe fatigue, sickness, and even myocardial infarction and other serious problems.

Tragically, Aranesp has been implicated in the development of potentially fatal blood clots, strokes, and cardiac arrest. While many of these dangerous clots begin in the lungs, they can quickly spread throughout the complex cardiovascular system to the heart or to the brain.

Medications that are similar to Aranesp have been linked to health problems in higher than average doses and the FDA has ordered the company that manufactures Aranesp - Amgen Pharmaceutical - to include this danger on warning labels. Many Aranesp users are unaware of the potential for serious injury. Because most patients using the medication already have immune systems that are weakened from the toxic effects of chemotherapy, adding such a risky drug into their bodies can be a recipe for disaster.

All patients deserve to be notified of the risks involved with their medications, particularly when the consequences can be so dire. If you are one of the victims of Aranesp or know someone else who is, make sure to get the guidance you deserve today. You may be entitled to financial compensation for your physical and emotional suffering, but you must act before restrictive statutes of limitations expire. Don't wait - call a compassionate and experienced Aranesp lawyer today.